Ricardo M Fernandes1, Amy C Plint2, Caroline B Terwee3, Cristina Sampaio4, Terry P Klassen5, Martin Offringa6, Johanna H van der Lee7. 1. Department of Pediatrics, Santa Maria Hospital, Lisbon Academic Medical Centre, Lisbon, Portugal; Clinical Pharmacology Unit, Instituto de Medicina Molecular, University of Lisbon, Lisbon, Portugal; rmfernandes@campus.ul.pt. 2. University of Ottawa and Children's Hospital of Eastern Ontario, Ottawa, Canada; 3. Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands; 4. Clinical Pharmacology Unit, Instituto de Medicina Molecular, University of Lisbon, Lisbon, Portugal; 5. Manitoba Institute of Child Health, University of Manitoba, Winnipeg, Canada; 6. ChildHealth Evaluative Sciences, Hospital for Sick Children, Toronto, Canada; and. 7. Division of Woman and Child, Pediatric Clinical Research Office, Academic Medical Centre, Amsterdam, Netherlands.
Abstract
BACKGROUND: The Respiratory Distress Assessment Instrument (RDAI) and Respiratory Assessment Change Score (RACS) are frequently used in bronchiolitis clinical trials, but evidence is limited on their measurement properties. We investigated their validity, reliability, and responsiveness. METHODS: We included data from up to 1765 infants with bronchiolitis enrolled in 2 studies conducted in pediatric emergency departments. We assessed RDAI construct validity by testing hypotheses of associations with physiologic measures (respiratory rate, oxygen saturation) and with constructs related to hospitalization, using correlation coefficients, and multivariable analysis. RDAI/RACS responsiveness was evaluated by using anchors of change based on these constructs; measures of responsiveness included the area under the curve. RDAI test-retest agreement and interrater reliability were evaluated by using limits of agreement and intraclass correlation coefficients. RESULTS: Baseline RDAI scores were weakly correlated with respiratory rate (r = 0.38, P < .001), and scores increased in lower oxygen saturation categories (P < .001). Higher RDAI scores were associated with hospitalization (odds ratio: 1.36; 95% confidence interval: 1.26-1.47); scores differed between participants who were discharged, admitted, or stayed in the emergency department (P < .001). Our hypotheses were met, but the magnitude of associations was below our predefined thresholds. RDAI test-retest limits of agreement were -3.80 to 3.64 (20% of the range), whereas interrater reliability was good (intraclass correlation coefficient = 0.93). Formulated hypotheses for responsiveness were confirmed, with moderate responsiveness (area under the curve: RDAI, 0.64-0.70; RACS, 0.72). CONCLUSIONS: RDAI has poor to moderate construct validity, with good discriminative properties but considerable test-retest measurement error. The RDAI and RACS are responsive measures of respiratory distress in bronchiolitis but do not encompass all determinants of disease severity.
BACKGROUND: The Respiratory Distress Assessment Instrument (RDAI) and Respiratory Assessment Change Score (RACS) are frequently used in bronchiolitis clinical trials, but evidence is limited on their measurement properties. We investigated their validity, reliability, and responsiveness. METHODS: We included data from up to 1765 infants with bronchiolitis enrolled in 2 studies conducted in pediatric emergency departments. We assessed RDAI construct validity by testing hypotheses of associations with physiologic measures (respiratory rate, oxygen saturation) and with constructs related to hospitalization, using correlation coefficients, and multivariable analysis. RDAI/RACS responsiveness was evaluated by using anchors of change based on these constructs; measures of responsiveness included the area under the curve. RDAI test-retest agreement and interrater reliability were evaluated by using limits of agreement and intraclass correlation coefficients. RESULTS: Baseline RDAI scores were weakly correlated with respiratory rate (r = 0.38, P < .001), and scores increased in lower oxygen saturation categories (P < .001). Higher RDAI scores were associated with hospitalization (odds ratio: 1.36; 95% confidence interval: 1.26-1.47); scores differed between participants who were discharged, admitted, or stayed in the emergency department (P < .001). Our hypotheses were met, but the magnitude of associations was below our predefined thresholds. RDAI test-retest limits of agreement were -3.80 to 3.64 (20% of the range), whereas interrater reliability was good (intraclass correlation coefficient = 0.93). Formulated hypotheses for responsiveness were confirmed, with moderate responsiveness (area under the curve: RDAI, 0.64-0.70; RACS, 0.72). CONCLUSIONS: RDAI has poor to moderate construct validity, with good discriminative properties but considerable test-retest measurement error. The RDAI and RACS are responsive measures of respiratory distress in bronchiolitis but do not encompass all determinants of disease severity.
Authors: Mary T Caserta; Xing Qiu; Brenda Tesini; Lu Wang; Amy Murphy; Anthony Corbett; David J Topham; Ann R Falsey; Jeanne Holden-Wiltse; Edward E Walsh Journal: J Infect Dis Date: 2017-03-01 Impact factor: 5.226
Authors: Kathryn M Schmit; Roger Brown; Supriya Hayer; Mary M Checovich; James E Gern; Ellen R Wald; Bruce Barrett Journal: Pediatr Res Date: 2021-02-24 Impact factor: 3.756
Authors: Antonio José Justicia-Grande; Jacobo Pardo-Seco; Miriam Cebey-López; Lucía Vilanova-Trillo; Alberto Gómez-Carballa; Irene Rivero-Calle; María Puente-Puig; Carmen Curros-Novo; José Gómez-Rial; Antonio Salas; José María Martinón-Sánchez; Lorenzo Redondo-Collazo; Carmen Rodríguez-Tenreiro; Federico Martinón-Torres Journal: PLoS One Date: 2016-06-21 Impact factor: 3.240